Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.

Condition:   Invasive Group B Streptococcus DiseaseIntervention:   Sponsors:   Novartis Vaccines;   NovartisActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials